| RECENT PATENT LITIGATION DrugPatentWatch tracks patent litigation to help you anticipate earlier-than-expected loss of exclusivity and generic entry opportunties which may emerge from patent invalidation or generic licensing. Complete litigation histories also allow you to observe your opponents and improve your strategies, and they can also help you write stronger patents based on studying prior challenges. | District Courts| ALNYLAM PHARMACEUTICALS, INC. V. MODERNA, INC. | | Court: | District Court, D. Delaware | | Cause: | 35:271 Patent Infringement | | Docket Number: | 1:22-cv-00335 | | Patents: | 10,143,723, 10,172,808, 8,008,006, 9,000,002 | | Drugs: | | | Date Filed: | 2022-03-17 | | Full Profile: | ALNYLAM PHARMACEUTICALS, INC. V. MODERNA, INC. at DrugPatentWatch |
| | MAYOR AND CITY COUNCIL OF BALTIMORE V. TEVA PHARMACEUTICALS INDUSTRIES LTD. | | | BAUSCH HEALTH IRELAND LIMITED V. MYLAN LABORATORIES LTD. | | Court: | District Court, N.D. West Virginia | | Cause: | 35:271 Patent Infringement | | Docket Number: | 1:22-cv-00020 | | Patents: | 10,011,637, 7,041,786, 7,799,897, 8,637,451, 9,610,321, 9,616,097, 9,919,024, 9,925,231 | | Drugs: | COPAXONE, TRULANCE | | Date Filed: | 2022-03-08 | | Full Profile: | BAUSCH HEALTH IRELAND LIMITED V. MYLAN LABORATORIES LTD. at DrugPatentWatch |
|
| Patent Trial and Appeal Board (PTAB)| Patent 10,138,279 | | Type: | IPR | | Trial Number: | IPR2022-00674 | | Petitioner: | TRUTEK CORP. | | Drugs: | BIOTHRAX | | Filing Date: | 2022-03-07 | | Full Profile: | IPR2022-00674 at DrugPatentWatch |
| | Patent 8,114,833 | | Type: | IPR | | Trial Number: | IPR2022-00657 | | Petitioner: | Fresenius Kabi USA, LLC | | Drugs: | OZEMPIC, SAXENDA, VICTOZA | | Filing Date: | 2022-03-03 | | Full Profile: | IPR2022-00657 at DrugPatentWatch |
| | Patent 8,580,264 | | Type: | IPR | | Trial Number: | IPR2022-00578 | | Petitioner: | Celltrion, Inc. | | Drugs: | ACTEMRA, RITUXAN, RITUXAN HYCELA | | Filing Date: | 2022-02-21 | | Full Profile: | IPR2022-00578 at DrugPatentWatch |
|
|
|
